Cost-utility analysis of dynamic intraligamentary stabilization versus early reconstruction after rupture of the anterior cruciate ligament by unknown
RESEARCH Open Access
Cost-utility analysis of dynamic
intraligamentary stabilization versus early
reconstruction after rupture of the anterior
cruciate ligament
Martin Bierbaum1* , Oliver Schöffski1, Benedikt Schliemann2 and Clemens Kösters2
Abstract
Objectives: The aim of this study was to evaluate the cost-effectiveness of the dynamic intraligamentary stabilization
(DIS) technique in comparison with reconstructive surgery (ACLR) in the treatment of isolated anterior cruciate
ligament (ACL) ruptures from the perspective of the community of insured citizens in Germany.
Methods: Because of the specific decision problem at hand, namely that with DIS the procedure has to take place
within 21 days after the initial trauma, a decision tree was developed.
The time horizon of the model was set to 3 years. Input data was taken from official tariffs, payer data, the literature
and assumptions based on expert opinion when necessary.
Results: The decision tree analysis identified the DIS strategy as the superior one with 2.34 QALY versus 2.26 QALY for
the ACLR branch. The higher QALY also came with higher costs of 5,398.05 € for the DIS branch versus 4,632.68 € for
the ACLR branch respectively, leading to an ICER of 9,092.66 € per QALY. Results were robust after sensitivity analysis.
Uncertainty was examined via probabilistic sensitivity analysis resulting in a slightly higher ICER of 9,567.13 € per QALY
gained.
Conclusion: The DIS technology delivers an effective treatment for the ACL rupture at a favorable incremental
cost-effectiveness ratio.
Background
The main cause for a rupture of the anterior cruciate
ligament (ACL) are non-contact injuries during football,
basketball, soccer and downhill skiing [1]. The US alone
spend over $1 billion on anterior cruciate ligament re-
constructions (ACLR) annually [2, 3]. In Germany more
than 30,000 ACLs are reconstructed every year leading
to about 113.3 Million € in hospital costs. In addition,
ACL tears lead to an array of indirect costs such as per-
sonal loss of income, government-funded injury leaves,
absence from school or university and the loss of condi-
tioning due to reduced activity [3]. Furthermore, rupture
of the ACL is strongly linked to osteoarthrosis with
many patients showing osteoarthritic changes and
related functional disability as early as 10 to 15 years
after initial injury [3]. Since mostly young people are
affected, the prevention of long-term results becomes
vitally important [4].
The current standard of care for an isolated rupture of
the ACL consists of two different strategies. The first
one is a wait and see strategy, also known as early re-
habilitation with delayed reconstruction if needed. Here
the patient tries to compensate the instability caused by
the torn ACL with muscular training. This treatment is
considered suitable for older and/or less active people. If
the patient is not satisfied with the outcome, he can still
choose reconstructive surgery later on [5, 6]. The second
strategy is early reconstructive surgery (ACLR in the
model). Hereby the torn ligament is reconstructed as
early as six weeks after the trauma [3]. For surgical
reconstruction a variety of procedures and techniques
(i.e. single bundle, double bundle, allo- or autograft)
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exist, but recent studies show no significant differences
regarding outcomes [2, 3, 6–8]. In practice younger pa-
tients are often treated surgically whereas older patients
are more often treated conservatively due to their lesser
demand to perform on a high activity level. Regarding
different age groups and sex, current study data suggests
that there is little difference in outcome between current
treatment strategies [9, 10].
With the dynamic intraligamentary stabilization (DIS)
a new treatment option became available. This technique
makes use of the healing potential of the ligament. The
surgical procedure is similar to the reconstruction, but
instead of removing and replacing the original ligament,
a supportive mechanism is set into the knee. With this
technology an intraarticular stabilization of the knee is
achieved which is accompanied by the healing of the
augmented ligament. A spring system (with 8 mm de-
flection) compensates the anisometry of the anterior
cruciate ligament. This mechanism fulfills the task of the
original ligament for the time of healing. Besides the re-
pair of the original ligament the technique has additional
advantages. It potentially preserves the proprioceptive
ability of the ligament, which may decrease the inci-
dence of re-tears and the development of posttraumatic
osteoarthrosis. Another advantage comes with the tim-
ing of the technique. Surgery needs to take place within
21 days after trauma. During the procedure, meniscal
tears can be acutely repaired at the same time, increas-
ing the probability of healing. This is especially import-
ant since available evidence suggests that the meniscal
status is the main driver for the development of osteoar-
throsis [3, 11–22].
Whereas before, wait and see was a viable strategy
and reconstructions could be performed as needed, de-
cision makers now face another strategy where time is
critical. Thus the aim of our study is to analyze the
cost-effectiveness of the dynamic intraligamentary
stabilization technology in comparison to early recon-
structive surgery as a benchmark of the current stand-
ard of care after the rupture of the anterior cruciate
ligament. Our purpose is to provide decision makers
with information for reimbursement decision concern-
ing this new technology.
Methods
Setting and perspective
The target population of our study are patients with an
isolated rupture of the anterior cruciate ligament with or
without meniscal injury who are eligible for the treat-
ment with the dynamic intraligamentary stabilization
system according to the instructions of use [23]. Study
setting is the German public healthcare sector with
patients covered by the statutory health insurance. As
far as surgical procedures are concerned the analysis is
limited to the inpatient setting, because only a small
number of patients are treated ambulatory. We chose
the perspective of the community of insured citizens. It
is the preferred perspective of the German HTA-body
IQWiG when evaluating interventions. The perspective
includes all direct costs, including reimbursable and out-
of-pocket medical costs [24]. In contrast to the societal
perspective it does not account for other social security
costs and indirect costs.
Input data
To gather the relevant information about the indication
as well as the data to populate the model we performed
a systematic literature search in the following databases:
Medline/PubMed, Cochrane Library, NHS-EED, Science-
Direct Navigator and Scopus. The findings about the indi-
cation were then summarized into an influence diagram
(see Additional file 1) which served as the basis for model
development. Due to the strong heterogeneity of the study
populations of the literature search it was not possible
to consolidate the relevant data in the form of a meta-
analysis. Instead we used the best evidence available
(i.e. Cochrane review) as baseline values wherever pos-
sible. Findings from other sources were then used for
the parameter ranges in the sensitivity analysis. Reim-
bursement rates were taken from the official tariffs.
The model calculates patient copayments accordingly.
Additional sources were statutory health fund data and
hospital data. Health fund data was analyzed and contrib-
uted by one of the largest health funds in Germany. Hos-
pital data was obtained from the participating hospitals in
the DIS study. Parameter uncertainty in the model is ad-
dressed via one-way and probabilistic sensitivity analysis.
Table 1 gives an overview of the input parameters and its
sources.
Costs
Since the costs for surgical treatment in the inpatient
sector are covered by a case based lump sum (flat fee)
we did not distinguish between different surgical ap-
proaches like single-bundle or double-bundle technique
or the use of allografts vs. autografts. In the outpatient
sector the situation is quite similar as well because the
operational procedures are covered by a case based lump
sum. Differences only occur in the coverage of the im-
plant, which might be reimbursed in some cases [25].
All prices are reported in 2014 Euros. Cost data is
based on sources assessed between 2012 and 2014, hence
there is no need for adjusting unit costs. The initial treat-
ment costs such as hospital charges, co-payments and
rehabilitation charges are all incurred within a few months
after the trauma. All other costs are discounted accord-
ingly. Discount rate is set as 3% and varied between 0%
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and 5% for sensitivity analysis. Outcomes are discounted
accordingly [26].
Quality of life
Treatment effects after ACL-rupture are often measured
with objective tests which do not necessarily reflect the
patient’s subjective health related quality of life (hrQoL)
[9, 15, 17, 27]. While many objective tests report signifi-
cant differences between treatment strategies, studies
assessing patient reported outcomes fail to support these
findings. Therefore, we decided to use quality adjusted
life years as the measure of benefit in our analysis.
To measure patient relevant outcomes, the SF-12
questionnaire was used to assess patient reported out-
comes in a prospective open label study comparing DIS
and ACLR. The study took place at the university hos-
pital of Münster, Germany and was approved by the
universities ethics committee. Informed consent to par-
ticipate in the study was obtained from all participants.
Questionnaires had to be filled out before surgery, at
6 weeks and at 6 and 12 months after surgery. Utilities
were derived from the SF-12 data with use of the Short
Form–6 dimensions (SF-6D) [28]. Due to the low enroll-
ment rates in the ACLR group the number of returned
questionnaires was insufficient for analysis (n = 9 at six
months and n = 2 at twelve months). So utilities for the
ACLR group had to be derived from the literature [6].
To make DIS study data and literature data comparable,
hrQoL values were standardized for the first 12 months
after injury. The input values and results are shown in
Table 2. The values for DIS are taken from the study data.
The values for ACLR where derived from Mather et al [6]
where we assumed the utility value for an unstable knee
to be equivalent to the quality of life before surgery which
incidentally equals the pre-op utility value from our study
data. The utility value for week 10 is directly taken from
the literature. For the remaining months we linearly ap-
proximated the 0,81 value from the literature. Since no
high quality data is available for hrQoL after revision
surgery we assume the hrQoL not to be worse than an
unstable knee in the ACLR group, which is a very con-
servative assumption in favor of the ACLR strategy.
Table 1 Input parameters
input parameter baseline-value SA/PSA Source
cost inpatient surgery (DIS & ACLR) 3,605.09€ - G-DRG catalogue
cost DIS (Ligamys) 1,284.00€ - Mathys AG, Bettlach
cost monobloc removal (DIS) 398.85 € 2,190.83€ Eggli et al. (2016) [33], expert opinion, G-DRG catalogue
cost medical devices (ACLR) 532.00€ - payer data
average costs of rehab per cycle 82.00€ - payer data
cost medication (ACLR) 117.92€ - official tariff (Lauer Taxe)
cost medication (DIS) 58.86€ - official tariff (Lauer Taxe)
disutility for revision surgery 0.05 0–0.1 Mather et al. (2014) [6]
monobloc removal rate (DIS) 0.241 0.05 Henle et al. (2015) [11]
probability of revision surgery (DIS) 0.029 - Henle et al. (2015) [11]
probability of revision surgery (ACLR) 0.025 0.0025–0.14 Janssen et al. (2012); Magnussen et al. (2010); Lind et al.
(2012); Frobell et al. (2013) [1, 4, 15, 31]
days in hospital (DIS) 2 - Henle et al. (2015) [11]
days in hospital (ACLR) 5 - Geiger et al. (2013) [25]
discount rate 0.03 0–0.05% german HTA guidelines [26]
number of prescriptions for rehab 2 - payer data
hrQoL baseline (DIS) 0.85 beta dist. 0.85 +/- 0.09 study data on file
hrQoL baseline (ACLR) 0.80 beta dist. 0.80 +/- 0.11 Mather et al. (2014) [6]
hrQoL first 12 m (DIS) 0.79375 beta dist. 0.79375 +/- 0.1 study data on file
hrQoL first 12 m (ACLR) 0.79813 beta dist. 0.79813 +/- 0.11 Mather et al. (2014) [6]
hrQoL after revision (DIS) lq_ACLR_norm Assumption; equals the baseline hrQoL of ACLR because
ACLR treatment is the revision therapy for DIS
hrQoL after revision (ACLR) 0.755 0.71–0.8 Lind/Menhert et al. (2012); Spindler et al. (2011); Lind/Lund
et al. (2012); Wright et al.(2011) [15, 17, 27, 30]
time to revision surgery in months (ACLR) 21.6 9.6–33.6 Lind/Menhert et al. (2012) [15]
time to revision surgery in months (DIS) 11.1 3.5–24.3 Henle et al. (2015) [11]
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Model development
In practice the decision in question has to be made
within 21 days after the trauma occurs and cannot be
redeemed afterwards. Given the decision problem at
hand we decided to use a decision tree [29]. Figure 1
shows the structure of the decision tree.
When early reconstruction and DIS are compared, the
initial physician contact and diagnostics after trauma are
basically the same in both strategies, hence they are not
incorporated into the model. Regarding the post-
operative care, we limited the analysis to the differences
between treatment strategies. Adverse events are not
taken into account too. They are very rare and available
study data suggests that they do not differ significantly
between treatment strategies. The same states for chon-
dral lesions, which occur seldom and do affect the out-
come only in severe cases, which are not treatable with
the strategies under scrutiny anyway [14, 16, 17].
Regarding revision surgery after treatment failure, the
model does distinguish between treatment strategies. Re-
vision in the DIS branch of the tree leads to costs of an
ACLR and subsequently to the hrQoL of ACLR for the
remaining time horizon. Revision in the ACLR branch
also leads to costs of an ACLR but is assigned a lower
health related quality of life for the remaining time hori-
zon because outcomes deteriorate significantly after a
second reconstruction [15, 17, 27, 30]. Re-revisions are
not incorporated into the model due to high uncertainty
and wide range of possible outcomes. Anyway, outcomes
deteriorate even further after re-revisions irrespective of
treatment strategy [15, 27].
Results
The decision tree analysis identified the DIS strategy as
the superior one with 2.34 QALY versus 2.26 QALY for
the ACLR branch. The higher QALY also came with
higher costs of 5,398.05€ for the DIS branch and
4,632.68€ for the ACLR branch respectively. The result-
ing ICER is 9,092.66€ per QALY.
Figure 2 shows the results of the univariate sensitivity
analysis. The main influencing variables are the probabil-
ity of revision surgery in the ACLR group and the costs
associated with the removal of the DIS monobloc. In
case of the incidence of revision surgery and the time-
frame within a revision surgery becomes necessary a lot
of inconsistent data exists, e.g. the reported rates for re-
vision surgery after an reconstruction of the anterior
cruciate ligament lie between 2.5% and 14%. So in the
base-case we used the lowest reported value of revision
incidence for ACLR. So it comes with no surprise that
the higher the rate of revision surgery in the ACLR
group, the more favorable the DIS strategy becomes.
Regarding the removal costs of the DIS monobloc it is the
other way around. Basically the procedure can be per-
formed with local anesthesia within 5 min in an ambulatory
setting. Nevertheless some physicians prefer to perform the
procedure in a hospital where the costs are much higher
and the ICER becomes less favorable. All the remaining
variables only have a marginal effect on the ICER.
Table 3 shows the results of the probabilistic sensitivity
analysis for the utilities, which are in line with the decision
tree results besides a slightly higher ICER of 9,567.13
€/QALY. The cost-effectiveness acceptability curve shows
Table 2 QALY calculation for the first year after surgery
DIS ACLR
Time hrQoL Time hrQoL
Injury to surgery (3 weeks) 0.71 Injury to surgery (6 weeks) 0.71
Surgery to week 6 0.71 - > 0.75 Surgery to week 10 0.71 - > 0.82
Week 6 to 6 months 0.75 - > 0.81 Week 10 to 12 month 0.82 - > 0.81
6 months to 12 months 0.81 - > 0.85
QALY for first year 0.79317 0.79813
Fig. 1 Decision Tree
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that beginning from a willingness to pay of 9,000 € per
QALY the DIS strategy is more likely to be cost-effective
(see Fig. 3).
Discussion
At present there is no concluding evidence available
whether wait and see or early intervention is the
dominant strategy [5, 31, 32]. Thus we started our
modeling approach by incorporating both strategies into
our model. While gathering the input data we had to
realize that there is no hrQoL data available for the wait
and see strategy. As a result, we limited our study to a
comparison between early reconstructive surgery and
dynamic intraligamentary stabilization. At first sight this
seems to be a severe limitation but regarding routine
practice our study still is of particular relevance.
Although it cannot be known a priori if a patient will
benefit from an early reconstruction, with today’s treat-
ment strategies patients are undergoing such procedures
notwithstanding. So if a patient decides against the wait
and see approach the question remains which early
intervention should be applied.
Fig. 2 Tornado ICER
Table 3 PSA analysis for effectiveness (1 Mio. runs)
Cost (SD) Effectiveness (SD)
ACLR 4,632.68€ 2.26 QALY (+/- 0.23)
95% CI: 1.75–2.63 QALY
DIS 5,398.05€ 2.34 QALY (+/- 0.19)
95% CI: 1.92–2.65 QALY
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The scope of our analysis is limited to the inpatient
setting due to data availability. Nevertheless, results
should not be affected whether surgical treatment is per-
formed out- or inpatient because overall reimbursement
does not differ significantly and literature does not indi-
cate differences in outcome. Furthermore, in Germany
the majority of procedures are performed at a hospital.
Moreover age and sex are not incorporated into the
model. Incidence of ACL rupture has its peak between
18 and 34 years of age, so long term consequences are
most likely to actually occur during the patients remaining
lifetime [10, 14, 16, 17]. Studies investigating outcomes
did not find clinical meaningful differences between
sexes [9, 10, 17].
The time horizon of the model is limited to 3 years
and cannot provide information about the long term
consequences. Ultimately the patient relevant consequences
are determined with the strategy chosen at the time of the
ACL rupture. A knee set to develop osteoarthrosis will de-
teriorate further the longer the time horizon. Some of the
patients will receive total knee endoprothesis, which would
definitely increase costs and lower quality of life. So given
today’s knowledge the results would shift in favor of the
DIS strategy the longer the time horizon of the model.
Until today it is still unclear what biomechanical ef-
fects lead to osteoarthrosis after an ACL-injury, whether
it is the ruptured ligament or the meniscal and cartilage
injuries. If it is the latter, every form of reconstruction is
Fig. 3 CE Acceptability Curve
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meaningless regarding the long term effects of osteoar-
throsis. Nevertheless, some therapies can provide better
quality of life in the meantime. The uncertainty sur-
rounding the connection between biomechanical effects
and outcomes is reflected in the large span between ex-
treme values for the probabilistic sensitivity analysis for
the hrQoL. As a consequence, the probability of DIS be-
ing cost-effective for a given willingness to pay is only
slightly above 50%. Therefore, payers are advised to im-
plement health services research alongside reimburse-
ment of the DIS technology. Irrespective of the model
results, the DIS technology additionally offers some ad-
vantages in the short term. First of all, with DIS there is
no need of harvesting tendons from the patient thus
resulting in a lower morbidity and preserving the ham-
string tendon for knee stability. Furthermore, it poten-
tially preserves the proprioceptive ability of the ligament.
Another advantage is the full weight bearing capacity
after surgery allowing a more aggressive rehabilitation
strategy leading to significant shorter time to work (31 vs.
65 days) respectively sports (141 vs. 185 days). Depending
on the patient’s demand this might lead to a considerably
higher quality of life shortly after the trauma.
Conclusion
Overall our findings fit with the current knowledge. There
is very strong evidence, that the long term outcomes are
mainly dependent on the meniscal status and some
studies point out that early intervention seems to have the
ability to delay or prevent further degradation of the
menisci [10]. Since the DIS technology by its nature offers
the earliest possible moment of intervention, the probabil-
ity of saving the menisci is much higher than with the
other treatment strategies and consequently a lesser
number of patients are likely to develop osteoarthrosis in
the long term. Since until today reconstructive surgery has
not been able to reduce the rate of development of
osteoarthrosis, it is rather probable that a successful pre-
ventative treatment must be delivered rapidly after injury
to address the early pattern of joint damage changes [3].
But not only does the DIS technology offer such an early
intervention with the potential to benefit patients with an
ACL rupture in long term, it also delivers a higher hrQoL
in the short term at a favorable ICER of 9092.66€ when it
is compared to early reconstruction.
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